Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit
Part of paid clinical trials in Memphis, Tennessee.
- Sponsor
- St. Jude Children's Research Hospital
- Study ID
- NCT06993688
- Status
- Recruiting
Conditions
- Cancer
- Communication
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Prognostic Communication-Patient/parent — BEHAVIORAL* Patient/parent identifies and selects a communication preferences companion (CPC) * CPC and patient/parent meet for a Communication Preferences Visit (CPV) * Oncologist, patient/parent, and CPC attend next disease re-evaluation visit together.
- Prognostic Communication-CPC — BEHAVIORAL* CPC reviews intervention materials and conversation guide with the research team * CPC and patient/parent meet for a CPV, and CPC documents patient/parent preferences in a templated form * CPC and oncologist discuss the CPV form * Oncologist, patient/parent, and CPC attend next disease re-evaluation visit together.
- Prognostic Communication-Oncologist — BEHAVIORAL* CPC and oncologist discuss the CPV form * Oncologist, patient/parent, and CPC attend next disease re-evaluation visit together
Study Details
The purpose of this research study is to obtain insights and feedback from patients and parents about a new approach to support conversations about how cancer may affect one's future life and quality of life (i.e., prognostic communication). This study involves creating a personalized approach to discussing prognosis. Primary Objectives * To evaluate the feasibility of implementing the RIGHTimeCPV intervention among pediatric oncology patients, caregivers, and clinicians (referred to herein as "shareholders"). * To assess the acceptability of the intervention across the shareholder groups. Secondary Objectives * To explore the potential impact of the RIGHTimeCPV intervention on communication quality, concordance in prognostic understanding, and therapeutic alliance between patients/families and multidisciplinary clinicians. * To explore whether the practice of eliciting, sharing, and honoring individualized communication preferences is sustained by clinicians after participation in the RIGHTimeCPV intervention.
Key Dates
- Start date
- Jun 16, 2025
- Status verified
- May 2026
- Primary completion
- Nov 1, 2027
- Completion
- Nov 1, 2027
Study Design
- Enrollment
- 85 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Other: RIGHTimeCPV intervention: Patients and Caregivers (parents)Pediatric patients aged 12-25 years with poor prognosis cancer who receive treatment at the study site or participating affiliate Caregivers of patients of any age who receive treatment at the study site (referred to as 'parent')
- Other: RIGHTimeCPV intervention: Psychosocial/nursing cliniciansPsychosocial/nursing clinicians who participate in the clinical care of participating patients/parents and serve as communication preferences companions (CPCs) under the auspices of this study
- Other: RIGHTimeCPV intervention: Pediatric oncologistsPediatric oncologists who treat participating patients/parents
Primary Outcome Measure
Feasibility of implementing the RIGHTimeCPV intervention [ Time Frame: Between Day 1-30 after a Disease Reevaluation Visit (DRV) [participant specific] and again 6 months after the final DRV during study exit interviews [participant specific ]
Central Contacts
- Erica C. Kaye, MD, MPH866-278-5833
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | Erica C. Kaye, MD,MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Memphis, TN
Related Studies
- Establishment of a Lifetime of Cohort of Adults Surviving Childhood CancerRecruiting · St. Jude Children's Research Hospital · Memphis, Tennessee
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Caris Biorepository Research ProtocolRecruiting · Caris Science, Inc. · Mobile, Alabama
- Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-upRecruiting · Center for Biomedical Research, LLC · Jacksonville, Florida